+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fibrin Sealant Market - Global Forecast 2026-2032- Product Image
Fibrin Sealant Market - Global Forecast 2026-2032- Product Image
Sale

Fibrin Sealant Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904497
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fibrin Sealant Market is projected to reach USD 584.59 Million in 2026. It is expected to continue growing at a CAGR of 14.50%, reaching USD 1.31 Billion by 2032.

Fibrin sealant is a biologic hemostatic and tissue-sealing technology that reproduces the final stage of coagulation by combining fibrinogen and thrombin at the point of care. In surgery, it is used as an adjunct when sutures, staples, cautery, or compression are insufficient or impractical, supporting hemostasis, sealing, and tissue adherence across cardiovascular, general, hepatic, orthopedic, neurosurgical, gynecologic, urologic, dental, and reconstructive procedures.

The market is shaped by rising surgical volumes, aging populations with higher comorbidity burdens, and the global push to reduce blood loss, transfusion exposure, operating-room time, and postoperative complications. Because fibrin sealants are typically plasma-derived or biologically sourced products, adoption is also closely tied to validated viral inactivation, cold-chain reliability, hospital formularies, regulatory compliance, and clinician confidence in product safety, preparation, and handling.

Transformative Shifts in the Fibrin Sealant Landscape

The fibrin sealant landscape is shifting from product-based procurement toward evidence-led perioperative value. Hospitals increasingly evaluate sealants through total cost of care, including transfusion avoidance, reduced drain output, shorter procedure time, and fewer reoperations. This is pushing suppliers to provide stronger clinical evidence, procedure-specific application systems, and training that improves consistency in real-world use.

Another major shift is the movement toward minimally invasive, robotic, and laparoscopic surgery. These techniques create demand for sprayable, easy-to-deliver sealants that perform in confined surgical fields. At the same time, regulatory scrutiny on plasma sourcing, biologic manufacturing controls, donor screening, pathogen reduction, labeling, and post-market surveillance is raising barriers to entry while favoring organizations with robust quality systems, strong hospital relationships, and global distribution capabilities.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the fibrin sealant ecosystem through better surgical planning, inventory control, demand forecasting, and post-market evidence generation. AI-enabled analytics can help hospitals identify procedures with high bleeding risk, optimize stock levels for biologic sealants with defined storage requirements, and reduce wastage linked to expiration, over-ordering, or inefficient allocation.

In clinical research and manufacturing, AI can accelerate literature surveillance, adverse-event signal detection, batch-quality trend analysis, and regulatory intelligence. Computer vision and surgical data platforms may eventually help quantify bleeding patterns, application technique, and sealant performance in operative fields, although current use remains supportive rather than autonomous. The cumulative impact is improved evidence generation, more targeted product utilization, and stronger alignment between sealant selection and patient-specific bleeding risk.

Key Regional Insights Across Major Markets

North America remains a high-value fibrin sealant market because of advanced surgical infrastructure, broad access to biologic hemostats, established blood-management programs, and mature reimbursement pathways across hospital systems. The United States drives most regional demand through high procedure volumes, specialty surgical centers, and early adoption of premium perioperative adjuncts, while Canada emphasizes evidence-based formulary decisions, centralized purchasing, and standardized procurement aligned with clinical governance.

Europe benefits from mature surgical care and strong adoption in countries with advanced hospital networks, particularly where complex cardiovascular, oncologic, transplant, and reconstructive procedures are concentrated. However, the EU Medical Device Regulation, biologics-related quality expectations, tender-based purchasing, and post-market evidence requirements increase compliance intensity. Asia-Pacific is the fastest-evolving opportunity area, supported by expanding surgical capacity in China, India, Japan, South Korea, and Australia, along with investment in tertiary hospitals, specialist training, and minimally invasive surgery. Latin America is led by Brazil and Mexico, where adoption is concentrated in private hospitals and advanced public institutions, while broader access remains linked to affordability and procurement cycles. The Middle East, particularly GCC countries, is investing in specialty surgery, healthcare infrastructure, and medical tourism, creating demand for advanced hemostatic technologies. Africa remains an emerging market where fibrin sealant access is shaped by hospital infrastructure, specialist availability, cold-chain capability, and budget prioritization.

Key Group Insights for Strategic Market Planning

ASEAN demand is supported by expanding private healthcare networks, rising procedure volumes, and government investment in hospital modernization across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, although pricing sensitivity, import dependence, and uneven specialist access influence adoption. The GCC shows stronger near-term strategic relevance because of high healthcare spending, advanced surgical centers, and demand for premium perioperative technologies in the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman.

The European Union is defined by stringent regulatory oversight, centralized purchasing in several countries, and high expectations for clinical evidence under evolving MDR and biologics quality requirements. BRICS countries represent scale-driven expansion, with China and India expanding surgical access, Brazil anchoring Latin American demand, Russia maintaining specialized hospital use under procurement and supply-chain constraints, and South Africa serving as a gateway for selected African healthcare systems. G7 markets remain innovation leaders due to advanced procedure mix, mature hospital infrastructure, strong pharmacovigilance, and established biologic safety standards. NATO-aligned healthcare systems often emphasize supply-chain resilience, emergency preparedness, quality-assured medical procurement, and secure access to critical surgical supplies, which can influence contracting priorities for fibrin sealants.

Key Country Insights in Fibrin Sealant Adoption

The United States is the most commercially significant country market, supported by high surgical volumes, strong specialty care, blood-conservation initiatives, and broad use of adjunctive hemostats in complex procedures. Canada follows a more centralized, evidence-driven adoption model focused on hospital formularies, clinical value, and procurement efficiency, while Mexico offers growth through private hospitals, urban tertiary centers, and surgical tourism. Brazil leads Latin America with advanced urban surgical centers, a large patient base, and strong demand in private and specialized public hospitals.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain consistent fibrin sealant demand through sophisticated hospital networks and established use in complex surgery. Germany’s clinical research base, surgical specialization, and quality-focused procurement support advanced biologic adoption, while France, Italy, Spain, and the United Kingdom emphasize evidence, reimbursement alignment, and hospital budget discipline. Russia remains a specialized-use market shaped by procurement policy, import dynamics, and availability in major referral hospitals. In Asia-Pacific, China and India offer high-volume potential as surgical access expands and tertiary care capacity improves. Japan and South Korea emphasize quality, safety, advanced surgical techniques, and strong regulatory oversight, while Australia supports adoption through developed hospital infrastructure, specialist practice standards, and strong clinical governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation that links fibrin sealant use with measurable perioperative outcomes, including hemostasis success, transfusion reduction, operating-room efficiency, complication avoidance, reduced drainage, lower reoperation risk, and cost offsets. Procedure-specific clinical data will be increasingly important for formulary access, surgeon confidence, hospital value-analysis committees, and payer acceptance.

Manufacturers should also invest in differentiated delivery systems for minimally invasive, laparoscopic, and robotic surgery, strengthen plasma-sourcing transparency, and build resilient cold-chain and biologics manufacturing capacity. Commercial teams should segment hospitals by specialty volume, bleeding-risk procedure mix, procurement model, and training needs, while medical affairs teams should expand hands-on education to reduce variability in preparation and application. Partnerships with AI-enabled surgical analytics and inventory platforms can further improve utilization discipline, wastage reduction, outcomes tracking, and evidence capture.

Research Methodology and Evidence Base

This executive summary is built from a structured secondary-research approach using publicly available regulatory, clinical, healthcare infrastructure, and market-access information. Sources considered include government health agencies, regulatory databases, peer-reviewed literature, product labeling, hospital procurement trends, surgical practice guidelines, hemovigilance references, and publicly available manufacturer disclosures where relevant.

The methodology evaluates fibrin sealant demand through clinical utility, procedure-volume drivers, safety and quality requirements, regional healthcare capacity, reimbursement conditions, procurement behavior, supply-chain requirements, and competitive positioning. Insights are triangulated across geographies and stakeholder groups to identify durable market patterns rather than short-term assumptions. No unverified numerical market sizing, market share, or unsupported forecasting claims are used in this summary.

Conclusion: Strategic Outlook for Fibrin Sealant

The fibrin sealant market is positioned for steady expansion as surgical teams seek reliable adjuncts that improve hemostasis, support sealing, reduce blood-management burden, and enhance perioperative efficiency. Adoption will be strongest where advanced surgical infrastructure, clinician training, biologic supply reliability, regulatory compliance, and reimbursement alignment converge.

Future competitiveness will depend on more than product availability. Leading suppliers will differentiate through clinical evidence, user-friendly delivery systems, regulatory excellence, AI-supported utilization insights, plasma-safety assurance, and region-specific access strategies. As hospitals increase scrutiny of outcomes and total cost of care, fibrin sealant suppliers that demonstrate measurable value and dependable supply will be best positioned for long-term adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fibrin Sealant Market, by Product Type
7.1. Introduction
7.2. Liquid
7.3. Patch
7.4. Spray
8. Fibrin Sealant Market, by Formulation Type
8.1. Introduction
8.2. Pre Mixed
8.3. Two Component Kits
9. Fibrin Sealant Market, by Technology
9.1. Introduction
9.2. Manual Application
9.3. Spray Application
10. Fibrin Sealant Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Bypass
10.2.2. Valve Repair
10.3. Dental
10.4. General Surgery
10.4.1. Abdominal
10.4.2. Thoracic
10.5. Neurosurgery
10.6. Orthopedic
10.6.1. Joint Reconstruction
10.6.2. Trauma Fixation
10.7. Wound Care
11. Fibrin Sealant Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Fibrin Sealant Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Fibrin Sealant Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Fibrin Sealant Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. B. Braun Melsungen AG
16.2. Baxter International Inc.
16.3. CryoLife, Inc.
16.4. CSL Behring GmbH
16.5. FzioMed Inc.
16.6. Haemacure Corporation
16.7. Hemarus Therapeutics (India) Pvt. Ltd.
16.8. Hemostasis LLC
16.9. Hualan Biological Engineering Inc.
16.10. Hunan Kelun-Biotech Co., Ltd.
16.11. Integra LifeSciences Corporation
16.12. Johnson & Johnson Services Inc
16.13. LFB Group
16.14. Mallinckrodt Pharmaceuticals Holdings Inc.
16.15. Omrix Biopharmaceuticals Ltd.
16.16. Sanofi S.A.
16.17. Shanghai Haoyuan Biological Manufacturing Co., Ltd.
16.18. Shanghai Hualan Biological Engineering Inc.
16.19. Shanghai RAAS Blood Products Co., Ltd.
16.20. Tissuemed Ltd.
List of Figures
FIGURE 1. GLOBAL FIBRIN SEALANT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FIBRIN SEALANT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FIBRIN SEALANT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FIBRIN SEALANT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FIBRIN SEALANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FIBRIN SEALANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL FIBRIN SEALANT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PATCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PATCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PATCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SPRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SPRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SPRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PRE MIXED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PRE MIXED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PRE MIXED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TWO COMPONENT KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TWO COMPONENT KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL TWO COMPONENT KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MANUAL APPLICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MANUAL APPLICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MANUAL APPLICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SPRAY APPLICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SPRAY APPLICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SPRAY APPLICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BYPASS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BYPASS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BYPASS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL VALVE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL VALVE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL VALVE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DENTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DENTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DENTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ABDOMINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ABDOMINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ABDOMINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL THORACIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL THORACIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL THORACIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NEUROSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ORTHOPEDIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ORTHOPEDIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ORTHOPEDIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TRAUMA FIXATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TRAUMA FIXATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TRAUMA FIXATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL WOUND CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL WOUND CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL WOUND CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. EUROPE FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. EUROPE FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. EUROPE FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 105. EUROPE FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 106. EUROPE FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. EUROPE FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 108. EUROPE FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 109. EUROPE FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 110. EUROPE FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. AFRICA FIBRIN SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. AFRICA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 123. AFRICA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 124. AFRICA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. AFRICA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 126. AFRICA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 127. AFRICA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 128. AFRICA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. ASEAN FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. ASEAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 132. ASEAN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASEAN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 134. ASEAN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. ASEAN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 136. ASEAN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 137. ASEAN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 138. ASEAN FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. GCC FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GCC FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. GCC FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 142. GCC FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. GCC FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. GCC FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 145. GCC FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 146. GCC FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 147. GCC FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. BRICS FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. BRICS FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. BRICS FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 160. BRICS FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. BRICS FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. BRICS FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 163. BRICS FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 164. BRICS FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 165. BRICS FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. G7 FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. G7 FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. G7 FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 169. G7 FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 170. G7 FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. G7 FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 172. G7 FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 173. G7 FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 174. G7 FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. NATO FIBRIN SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. NATO FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. NATO FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 178. NATO FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. NATO FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. NATO FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 181. NATO FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 182. NATO FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 183. NATO FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. CANADA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 195. CANADA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 196. CANADA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 197. CANADA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. CANADA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. CANADA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 200. CANADA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 201. CANADA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 202. CANADA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. MEXICO FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. MEXICO FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. MEXICO FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 206. MEXICO FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. MEXICO FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. MEXICO FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 209. MEXICO FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 210. MEXICO FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 211. MEXICO FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. BRAZIL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. BRAZIL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. GERMANY FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. GERMANY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. GERMANY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 233. GERMANY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. GERMANY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. GERMANY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 236. GERMANY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 237. GERMANY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 238. GERMANY FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. FRANCE FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. FRANCE FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. FRANCE FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 242. FRANCE FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 243. FRANCE FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. FRANCE FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 245. FRANCE FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 246. FRANCE FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 247. FRANCE FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. RUSSIA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. RUSSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. RUSSIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 254. RUSSIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. ITALY FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. ITALY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. ITALY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 260. ITALY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. ITALY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. ITALY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 263. ITALY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 264. ITALY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 265. ITALY FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. SPAIN FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. SPAIN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. SPAIN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 269. SPAIN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. SPAIN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. SPAIN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 272. SPAIN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 273. SPAIN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 274. SPAIN FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. CHINA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. CHINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. CHINA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 278. CHINA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 279. CHINA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. CHINA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 281. CHINA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 282. CHINA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 283. CHINA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. INDIA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. INDIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. INDIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 287. INDIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 288. INDIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. INDIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 290. INDIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 291. INDIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 292. INDIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. JAPAN FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. JAPAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. JAPAN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 296. JAPAN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 297. JAPAN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. JAPAN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 299. JAPAN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 300. JAPAN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 301. JAPAN FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. AUSTRALIA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. GLOBAL FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 321. GLOBAL FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • CryoLife, Inc.
  • CSL Behring GmbH
  • FzioMed Inc.
  • Haemacure Corporation
  • Hemarus Therapeutics (India) Pvt. Ltd.
  • Hemostasis LLC
  • Hualan Biological Engineering Inc.
  • Hunan Kelun-Biotech Co., Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services Inc
  • LFB Group
  • Mallinckrodt Pharmaceuticals Holdings Inc.
  • Omrix Biopharmaceuticals Ltd.
  • Sanofi S.A.
  • Shanghai Haoyuan Biological Manufacturing Co., Ltd.
  • Shanghai Hualan Biological Engineering Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Tissuemed Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 584.59 Million
Forecasted Market Value ( USD ) by 2032 $ 1310 Million
Compound Annual Growth Rate14.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Fibrin Sealants - Global Strategic Business Report - Product Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Fibrin Sealants Market Report 2026 - Product Image

Fibrin Sealants Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Fibrin Sealants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Fibrin Sealants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Fibrin Degradation Products Assay Kit Market - Global Forecast 2026-2032 - Product Image

Fibrin Degradation Products Assay Kit Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Platelet-Rich Fibrin (PRF) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Platelet-Rich Fibrin (PRF) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From

About the Fibrin Sealant Market

Fibrin Sealant is a type of wound care product used to help close and heal wounds. It is a biologic product made from human plasma proteins that are used to help stop bleeding and promote healing. Fibrin Sealant is used to help close surgical incisions, reduce the risk of infection, and reduce the need for sutures. It is also used to help close traumatic wounds, such as those caused by burns or lacerations. Fibrin Sealant is often used in combination with other wound care products, such as dressings, to help promote healing. Fibrin Sealant is a growing market within the wound care industry. It is used in a variety of medical settings, including hospitals, clinics, and home care. It is also used in a variety of surgical procedures, including orthopedic, cardiovascular, and plastic surgery. Some companies in the Fibrin Sealant market include Baxter, CSL Behring, Grifols, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.